Global Medical REIT (GMRE) announces Board director Ronald Marston will retire at 2026 meeting

Rhea-AI Filing Summary

Global Medical REIT Inc. reported that director Ronald Marston has informed the Board that he intends to retire as a director, effective at the company’s 2026 Annual Meeting of Stockholders. He will not stand for re-election, and his service will conclude when his current term expires at that meeting. The company stated that Mr. Marston’s decision to retire is not due to any disagreement with Global Medical REIT regarding its operations, policies, or practices, indicating this is a planned governance transition rather than a response to a specific dispute.

false 0001533615 0001533615 2025-12-03 2025-12-03 0001533615 us-gaap:CommonStockMember 2025-12-03 2025-12-03 0001533615 us-gaap:SeriesAPreferredStockMember 2025-12-03 2025-12-03 0001533615 us-gaap:WarrantMember 2025-12-03 2025-12-03 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(D) OF THE 

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): December 4, 2025 (December 3, 2025)

Global Medical REIT Inc.

(Exact name of registrant as specified in its charter)

Maryland	001-37815	46-4757266
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(I.R.S. Employer Identification No.)

7373 Wisconsin Avenue, Suite 800

Bethesda, MD

20814

(Address of Principal Executive
Offices)

(Zip Code)

(202) 524-6851

(Registrant’s Telephone Number, Including Area Code)

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class:		Trading Symbols:		Name of each exchange on which registered:
Common Stock, par value $0.001 per share		GMRE		NYSE
Series A Preferred Stock, par value $0.001 per share		GMRE PrA		NYSE
Series B Preferred Stock, par value $0.001 per share		GMRE PrB		NYSE

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On December 3, 2025, Mr. Ronald Marston notified the Board of Directors (the “Board”) of Global Medical REIT Inc. (the “Company”) that he intends to retire as a director of the Company, effective as of the Company’s 2026 Annual Meeting of Stockholders (the “Annual Meeting”). Accordingly, Mr. Marston will not be nominated by the Board for election as a director at the Annual Meeting, and Mr. Marston’s position as a director will end when his current term expires on the date of the Annual Meeting. Mr. Marston’s decision to retire was not a result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practice.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Global Medical REIT Inc.
	By:		/s/ Jamie A. Barber
			Jamie A. Barber
			Secretary and General Counsel

Date: December 4, 2025

FAQ

What did Global Medical REIT Inc. (GMRE) announce in this 8-K filing?

Global Medical REIT Inc. announced that director Ronald Marston intends to retire from the Board, effective at the company’s 2026 Annual Meeting of Stockholders, and will not be nominated for re-election.

When will Ronald Marston’s term as a director of GMRE end?

Ronald Marston’s position as a director will end when his current term expires on the date of Global Medical REIT’s 2026 Annual Meeting of Stockholders.

Is Ronald Marston leaving Global Medical REIT due to a disagreement with the company?

No. The company stated that Mr. Marston’s decision to retire was not a result of any disagreement with Global Medical REIT on matters related to its operations, policies, or practices.

Will Ronald Marston be nominated for re-election to the GMRE Board?

No. Global Medical REIT’s Board will not nominate Ronald Marston for election as a director at the 2026 Annual Meeting of Stockholders.

Which form did Global Medical REIT use to disclose Ronald Marston’s planned retirement?

Global Medical REIT disclosed Ronald Marston’s planned retirement from the Board on a Form 8-K under the item covering departures and appointments of directors and certain officers.

Who signed the GMRE 8-K related to Ronald Marston’s retirement?

The 8-K was signed on behalf of Global Medical REIT Inc. by Jamie A. Barber, who is the company’s Secretary and General Counsel.